Literature DB >> 1856212

Identification of critical amino acid residues in human and mouse granulocyte-macrophage colony-stimulating factor and their involvement in species specificity.

A B Shanafelt1, K E Johnson, R A Kastelein.   

Abstract

Segments critical to the activity of human granulocyte-macrophage colony-stimulating factor (GM-CSF) were identified by scanning deletion analysis and compared with the critical regions previously identified in the homologous mouse GM-CSF protein. Three of the four critical regions thus identified are in equivalent positions in their respective polypeptides, while a fourth critical region of each is uniquely located. To investigate whether unique critical regions are responsible for the observed species specificity of human and mouse GM-CSF, all critical regions were substituted into their opposite homologue. This identified one specific, but different, critical region in each homologue that could not be replaced. Further characterization of the nature of the species specificity of these two proteins was accomplished by the generation of a series of human/mouse GM-CSF hybrids. Each hybrid protein was assayed for specific activity on human- and mouse GM-CSF-dependent cell lines. Significant differences in the specific activity of these hybrids was observed, suggesting that different segments of each molecule interact with their respective receptors. Based on these two approaches, individual amino acids were identified that could provide, at least in part, the interactions between these protein ligands and their respective receptors. These residues are Thr-78 and Met-80 in human GM-CSF and Asp-92, Thr-98, and Asp-102 in mouse GM-CSF.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1856212

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2Rγ(null) mice.

Authors:  Simon N Robinson; Paul J Simmons; Michael W Thomas; Nathalie Brouard; Jeannie A Javni; Suprita Trilok; Jae-Seung Shim; Hong Yang; David Steiner; William K Decker; Dongxia Xing; Leonard D Shultz; Barbara Savoldo; Gianpietro Dotti; Catherine M Bollard; Leonard Miller; Richard E Champlin; Elizabeth J Shpall; Patrick A Zweidler-McKay
Journal:  Exp Hematol       Date:  2012-02-02       Impact factor: 3.084

2.  Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer.

Authors:  Simona Bramante; Anniina Koski; Ilkka Liikanen; Lotta Vassilev; Minna Oksanen; Mikko Siurala; Raita Heiskanen; Tiina Hakonen; Timo Joensuu; Anna Kanerva; Sari Pesonen; Akseli Hemminki
Journal:  Oncoimmunology       Date:  2015-08-27       Impact factor: 8.110

3.  Bovine alpha s1-casein gene sequences direct high level expression of human granulocyte-macrophage colony-stimulating factor in the milk of transgenic mice.

Authors:  M Uusi-Oukari; J M Hyttinen; V P Korhonen; A Västi; L Alhonen; O A Jänne; J Jänne
Journal:  Transgenic Res       Date:  1997-01       Impact factor: 2.788

4.  Hematopoietic cytokines: similarities and differences in the structures, with implications for receptor binding.

Authors:  A Wlodawer; A Pavlovsky; A Gustchina
Journal:  Protein Sci       Date:  1993-09       Impact factor: 6.725

Review 5.  The Development of Next-generation PBMC Humanized Mice for Preclinical Investigation of Cancer Immunotherapeutic Agents.

Authors:  Y Maurice Morillon; Ariana Sabzevari; Jeffrey Schlom; John W Greiner
Journal:  Anticancer Res       Date:  2020-10       Impact factor: 2.480

6.  A human interleukin 3 analog with increased biological and binding activities.

Authors:  A F Lopez; M F Shannon; S Barry; J A Phillips; B Cambareri; M Dottore; P Simmons; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

Review 7.  The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease.

Authors:  Timothy R Hercus; Daniel Thomas; Mark A Guthridge; Paul G Ekert; Jack King-Scott; Michael W Parker; Angel F Lopez
Journal:  Blood       Date:  2009-05-12       Impact factor: 22.113

8.  Oncolytic and immunostimulatory efficacy of a targeted oncolytic poxvirus expressing human GM-CSF following intravenous administration in a rabbit tumor model.

Authors:  J-H Lee; M-S Roh; Y-K Lee; M-K Kim; J-Y Han; B-H Park; P Trown; D H Kirn; T-H Hwang
Journal:  Cancer Gene Ther       Date:  2009-07-24       Impact factor: 5.987

9.  Residue 21 of human granulocyte-macrophage colony-stimulating factor is critical for biological activity and for high but not low affinity binding.

Authors:  A F Lopez; M F Shannon; T Hercus; N A Nicola; B Cambareri; M Dottore; M J Layton; L Eglinton; M A Vadas
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

10.  The amino-terminal helix of GM-CSF and IL-5 governs high affinity binding to their receptors.

Authors:  A B Shanafelt; A Miyajima; T Kitamura; R A Kastelein
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.